APA (7th ed.) Citation

M, D., JP, P., JR, S., C, E., S, A., MA, J., . . . P, M. (2021). No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study. Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132856

Chicago Style (17th ed.) Citation

M, Dominguez-Valentin, et al. "No Difference in Penetrance Between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study." Journal of Clinical Medicine 10, no. 13 (2021). https://doi.org/10.3390/jcm10132856.

MLA (9th ed.) Citation

M, Dominguez-Valentin, et al. "No Difference in Penetrance Between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study." Journal of Clinical Medicine, vol. 10, no. 13, 2021, https://doi.org/10.3390/jcm10132856.